The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells

Adipocytes Cause Leukemia Cell Resistance to L-Asparaginase via Release of Glutamine

(2013) E. A. Ehsanipour et al.   CANCER RESEARCH

Unraveling the Enigmatic Mechanism of l-Asparaginase II with QM/QM Calculations

(2013) Diana S. Gesto et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Glutamine supplementation in acute pancreatitis: A meta-analysis of randomized controlled trials

(2013) Varsha Asrani et al.   PANCREATOLOGY

Pancreatic Tumor Sensitivity to Plasma L-Asparagine Starvation

(2012) Emmanuelle Dufour et al.   PANCREAS

Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts

(2012) Barbara Szymanska et al.   PLoS One

Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity

(2010) M. N. Offman et al.   BLOOD

Structure-Function Relationships and Clinical Applications of L-Asparaginases

(2010) N.E. Labrou et al.   CURRENT MEDICINAL CHEMISTRY

DNA fingerprinting of the NCI-60 cell line panel

(2009) P. L. Lorenzi et al.   MOLECULAR CANCER THERAPEUTICS

Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines

(2008) Philip L. Lorenzi et al.   MOLECULAR CANCER THERAPEUTICS

Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines

(2007) Nan Su et al.   PEDIATRIC BLOOD & CANCER